← Back

BIIB · Nasdaq · Biological Products, (No Diagnostic Substances)

Biogen Inc.

Overview

Biogen Inc. is listed on Nasdaq and classified as Biological Products, (No Diagnostic Substances). We have no business description beyond that classification; its SEC filings describe the business.

What we have on this company
InformationStatusAs of
Detailed research reportNo report
Rule-based screensOn 1 shortlist: Top Momentum2026-10-31
ValuationModel 159.11 (-37% vs price)2026-10-31
Chart-pattern readNo read
Paper portfolioNever held

Scores

Deterministic rule outputs, snapshot 2026-10-31 · price 253.62 on 2026-10-30. Not recommendations.

On the current shortlists: Top Momentum (#9).

MethodScoreInputs as ofFlags
Graham Defensive412025-12-31 partial, missing 2b stale input
Magic Formulan/a
Momentum852026-10-30
Insider02026-10-30
Buffett Quality692026-09-30 partial, missing 5
Lynch GARP312026-09-30
Graham Enterprising402026-09-30
Piotroski F-Score44 partial, missing 5,8

Every input with its filing: full score sheet · research packet (JSON) · Markdown · SEC filings.

Valuation

Model estimate from SEC filings · calculated 2026-10-31 from the 2026-10-30 close · filings through 2026-10-28

159.11 -37% vs price

Range 139.84 to 223.34, 3 of 3 methods agree. A labelled model estimate, not a price target. Method.